GlassScriptPhysician profile
Jacquelyn Kalv
NPI 1568848109
$218.97
in general payments reported to CMS, 2019-2025
9 companies · $88.97 in 2025
The $88.97 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $32.14 · 2024: $97.86 · 2025: $88.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $218.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $44.49 | 2023-2025 | Gattex |
| Merck Sharp & Dohme LLC | $32.72 | 2024 | Lynparza, Keytruda |
| Acera Surgical, INC. | $24.91 | 2025 | Restrata Wound Matrix |
| Molnlycke Health Care US, LLC | $24.13 | 2024 | Mepilex Border Post-Op Ag |
| Davol INC. | $23.53 | 2024 | Arista Ah Flexitip |
| Integra Lifesciences Corporation | $21.74 | 2025 | Integra, Omnigraft, Surgimend |
| Lilly USA, LLC | $18.28 | 2025 | Zepbound |
| Merit Medical Systems INC | $17.48 | 2024 | Savi Scout |
| My01 INC. | $11.69 | 2023 | My01 Continuous Compartmental Pressure Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacquelyn Kalv listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.